PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System

por Ivos, R., Ribeiro-Vaz, I., Polónia, J., Silva, A.
Publicado 2021

ISVH Society September Newsletter

por Roberts, W.C., Zanchetti, A., Asmar, R., Cameron, J., Achimastos, A., Agabiti-Rosei, E., Cockcroft, J., Duprez, D., Filipovsky, J., Izzo, J., Nicolaides, A., Sa Cunha, R., Struijker-Boudier, H., Takazawa, K., Van Bortel, L., Wang, H., Benetos, A., Calvo, C., Cohn, J.N., Cruickshank, K., de Leeuw, P., de Luca, N., Feely, N., Franklin, S., Kass, D., Kingwell, B., Koh, K.K., Laurent, S., Mitchell, G., Palma-Gamiz, J., Pannier, B., Park, C.G., Polonia, J., Rajkumar, C., Schiffrin, E., Scuteri, A., Sirenko, Y., Topouchian, J., Toto-Moukouo, J., Van Meighem, W., Waeber, B.
Publicado 2007